TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection

Inclusion Criteria: * Male or female patients \> 18 years and \<=70 years of age. * Pathological evidence of ICC * Tumors can be completely resected. * Criteria of liver function: Child A-B level, serum bilirubin ≤ 1.5 times the upper limit of normal value, alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value. * Patients who can understand this trial and have signed information consent. Exclusion Criteria: * Tumors can not be resected . * Patients with apparent cardiac, pulmonary, cerebral and renal dysfunction, which may affect the treatment of Intrahepatic cholangiocarcinoma. * Patients with a medical history of other malignant tumors. * Subjects participating in other clinical trials. * Liver function:Child C.